4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001181431-06-040954
Options or other derivatives
- President and CEO acquired 250,000 shares (grant or award)
From the SEC's structured data for this filing
Oncotelic Therapeutics, Inc. Filed Acc 0001181431-06-040954
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…